A.I. Learns to Write in DNA
Scientists prompted A.I. to design and create new viruses for the first time, a milestone for medicine that also raises new biosecurity concerns.
Members of the European Parliament announced an open AMA session this week focused on how Europe should regulate artificial intelligence, inviting developers, researchers, and the general public to submit questions directly to the lawmakers shaping the rules.
The timing matters. The EU AI Act is now in its enforcement phase, and the hard implementation questions � which systems qualify as high-risk, what obligations fall on general-purpose AI providers, how copyright exceptions work for training data � are being hammered out in real time. An open forum gives the developer community a direct channel that lobbying efforts typically do not.
Europe has effectively become the world's de facto AI regulator by virtue of market size and the extraterritorial reach of its rules. Companies building for any European user are already building to EU standards whether they want to or not, which means what gets decided in Brussels tends to set a global floor.
Whether the AMA produces anything substantive or becomes a PR exercise depends entirely on which questions get answered and how directly. The transcript will be worth reading regardless.
All comments are reviewed before appearing. Keep it respectful.
Scientists prompted A.I. to design and create new viruses for the first time, a milestone for medicine that also raises new biosecurity concerns.
The Trump administration has no idea on how to handle open-source and open-weight AI models from China.
Google is consolidating AI leadership in California but the reorganization is pushing out the engineers who built its AI division